EssilorLuxottica and Burberry announce licensing partnership renewal EssilorLuxottica and Burberryannounce licensing partnership renewal Paris, France and London, United Kingdom (18 December 2025) – EssilorLuxottica and Burberry today announced the renewal of their licensing agreement for the development, production and global distribution of eyewear under the Burberry brand. The existing agreement, expiring on December 31, 2025, has been extended through December 31, 2035. Building on a shared legacy of creativity, craftsmanship and innovation, the renewal reinforces a long-standing pa...
EssilorLuxottica et Burberry renouvellent leur accord de licence EssilorLuxottica et Burberryrenouvellent leur accord de licence Paris, France et Londres, Royaume-Uni (18 décembre 2025) – EssilorLuxottica et Burberry ont annoncé aujourd’hui le renouvellement de leur accord de licence pour la conception, la production et la distribution mondiale de lunettes sous la marque Burberry. L’accord en vigueur, venant à échéance le 31 décembre 2025, a été prolongé jusqu’au 31 décembre 2035. S'appuyant sur une culture partagée de créativité, de savoir-faire et d'innovation, ce renouvellement vient...
EssilorLuxottica e Burberry rinnovano l’accordo di licenza EssilorLuxottica e Burberry rinnovano l’accordo di licenza Parigi, Francia e Londra, Regno Unito (18 dicembre 2025) – EssilorLuxottica e Burberry annunciano il rinnovo dell’accordo di licenza per lo sviluppo, la produzione e la distribuzione a livello globale di occhiali a marchio Burberry. L’accordo in essere, con scadenza prevista il 31 dicembre 2025, viene rinnovato fino al 31 dicembre 2035. Con una tradizione condivisa di creatività, artigianalità e innovazione, il rinnovo rafforza una collaborazione avviata tra le due socie...
EssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprint EssilorLuxottica to acquire Signifeye,further growing its ophthalmology clinics footprint Paris, France (12 December 2025) – EssilorLuxottica announced today the acquisition of Signifeye, a leading Belgian ophthalmology platform delivering top-tier patient care across 15 eye centers and clinics in the Flanders region. The transaction comes soon after the recent acquisition of Optegra, a fast-growing and highly integrated ophthalmology platform in Europe operating over 70 clinics in the UK, Czech Re...
EssilorLuxottica va acquérir Signifeye, poursuivant l’extension de son réseau de cliniques ophtalmologiques EssilorLuxottica va acquérir Signifeye,poursuivant l’extension de son réseau de cliniques ophtalmologiques Paris, France (12 décembre 2025) – EssilorLuxottica a annoncé aujourd’hui l’acquisition de Signifeye, une plateforme d’ophtalmologie belge de premier plan qui propose aux patients des prestations médicales de haut niveau grâce à 15 cliniques et centres de l’œil situés en Flandre. Cette transaction fait suite à la récente acquisition d’Optegra, une plateforme européenne d'ophta...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.